Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

62
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
62
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

146
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
146
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

95
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
95
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

156
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
156
Relative Risk01:12

Relative Risk

116
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
116
Contingency Table01:29

Contingency Table

2.4K
A contingency table provides a way of portraying data that can facilitate calculating probabilities. It is a method of displaying a frequency distribution as a table with rows and columns to show how two variables may be dependent (contingent) upon each other; The table helps determine conditional probabilities quite quickly and can help systematically organize, analyze and quantify data. The table displays sample values concerning two variables that may be dependent or contingent on one...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lavandin cell extract enriched in rosmarinic acid attenuates inflammation via AMPK/Nrf2/HO-1 activation and IKK/IκB/NF-κB inhibition.

BMC plant biology·2026
Same author

Avoid All the Competitive Ones: Dynamics of Altruistic Behavior, Mediators, and Moderators in an Evacuation Drill.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.

Transplantation and cellular therapy·2026
Same author

A ratiometric fluorescent reporter of mitochondrial sodium.

Nature chemical biology·2026
Same author

STAT6 inhibition of M2 macrophages suppresses tumor growth by modulating the tumor microenvironment in colon cancer model.

Frontiers in immunology·2026
Same author

Antioxidant Supplementation with Caffeine During Rescue In Vitro Maturation Improves Fertilization and Embryo Development in Women of Advanced Maternal Age.

Antioxidants (Basel, Switzerland)·2026
Same journal

Residual-Based Sieve Maximum Full Likelihood Estimation for the Proportional Hazards Model.

Communications in statistics: theory and methods·2026
Same journal

A Note on the Complementary Mixture Pareto II Distribution.

Communications in statistics: theory and methods·2026
Same journal

Parameter-expanded data augmentation for analyzing multinomial probit models.

Communications in statistics: theory and methods·2025
Same journal

Sample size estimation for the ratio of count outcomes in a cluster randomized trial using GEE.

Communications in statistics: theory and methods·2025
Same journal

Regression Modeling of Cumulative Incidence Function for Left-Truncated Right-Censored Competing Risks Data: A Modified Pseudo-observation Approach.

Communications in statistics: theory and methods·2025
Same journal

Identifiability and convergence behavior for Markov chain Monte Carlo using multivariate probit models.

Communications in statistics: theory and methods·2025
See all related articles

Related Experiment Video

Updated: Jun 3, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Competing risks regression for clustered data with covariate-dependent censoring.

Manoj Khanal1, Soyoung Kim1, Xi Fang1

  • 1Division of Biostatistics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, 53226, Wisconsin,USA.

Communications in Statistics: Theory and Methods
|January 10, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical model for analyzing competing risks data with clustering and dependent censoring, improving accuracy in clinical trials. The method accurately estimates parameters, offering better insights into complex health outcomes.

Keywords:
Competing risks regressionCovariate dependent censoringProportional subdistribution hazards modelStratified model

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

211

Related Experiment Videos

Last Updated: Jun 3, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

211

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Epidemiology

Background:

  • Competing risks data in clinical studies often exhibit cluster effects (e.g., center effects, matched pairs).
  • The proportional subdistribution hazards (PSH) model is standard for competing risks, but existing methods for clustered data lack covariate-dependent censoring and stratification.
  • Real-world data frequently involve covariate-dependent censoring and non-proportional hazards structures.

Purpose of the Study:

  • To propose a novel marginal stratified PSH model for clustered competing risks data.
  • To address limitations of existing methods by incorporating covariate-dependent censoring and stratification.
  • To evaluate the model's performance and apply it to leukemia patient data.

Main Methods:

  • Developed a marginal stratified PSH model with covariate-adjusted censoring weight for clustered data.
  • Utilized a marginal stratified proportional hazards model to estimate censoring probabilities, accounting for clusters and non-proportional hazards.
  • Conducted simulation studies to assess parameter estimation and coverage rates.

Main Results:

  • The proposed method yields unbiased parameter estimates in the presence of covariate-dependent censoring.
  • Simulation results demonstrate approximate 95% coverage rates, indicating good performance.
  • The method was successfully applied to stem cell transplant data to analyze HLA matching effects on graft-versus-host disease.

Conclusions:

  • The proposed marginal stratified PSH model effectively handles clustered competing risks data with covariate-dependent censoring and non-proportional hazards.
  • This approach offers a more robust and accurate analysis for complex clinical datasets.
  • The findings have implications for understanding donor-recipient matching in leukemia transplantation.